CAS 1337878-62-2

ATI-2341

CAS : 1337878-62-2

ATI-2341, pepducin targeting the CXCR4, is an allosteric agonist activating the Gi to promote inhibition of cAMP production and induce calcium mobilization.

Formule : C₁₀₄H₁₇₈N₂₆O₂₅S₂

Couleur et forme : Solid

Masse moléculaire : 2256.82

Ref: TM-T6764

ATI 2341

CAS : 1337878-62-2

ATI 2341 is a colony-stimulating factor that belongs to the group of pharmaceutical drugs. It is used in cancer diagnosis and treatment, as well as for the prevention of chemotherapy-induced neutropenia. ATI 2341 is a chemokine that binds to the chemokine receptors CXCR4 and CXCR7. ATI 2341 has an inhibitory effect on chemotaxis and inflammatory activity in macrophages. This drug also has a heteromeric complex with other chemokines, such as IL-8, MCP-1, or MIP-1α. ATI 2341 interacts with these other chemokines by binding to their specific agonists, which are found on human immunodeficiency virus (HIV) section cells or cancer cells.

Formule : C₁₀₄H₁₇₈N₂₆O₂₅S₂

Degré de pureté : Min. 95%

Masse moléculaire : 2,256.82 g/mol

Ref: 3D-MDC87862